HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Previous close
$0.62
Year range
$0.51 - $0.88
Market cap
32.14M CAD
Avg Volume
28.00K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.39M | 253.27% |
Net income | -2.38M | -262.94% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.50M | -15.55% |
Total assets | 3.63M | -14.77% |
Total liabilities | 1.47M | 1,289.66% |
Total equity | 2.15M | — |
Shares outstanding | 51.84M | — |
Price to book | 15.50 | — |
Return on assets | -215.11% | — |
Return on capital | -458.68% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.38M | -262.94% |
Cash from operations | -2.12M | -154.41% |
Cash from investing | — | — |
Cash from financing | 3.81M | 54,351.57% |
Net change in cash | 1.66M | 301.49% |
Free cash flow | -1.24M | -105.53% |
About
Founded
2018
Headquarters
Website
